# Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions

> **NCT02323672** · — · COMPLETED · sponsor: **Cairo University** · enrollment: 45 (actual)

## Conditions studied

- Precancerous Conditions
- Oral Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02323672
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-09
- **Final completion:** 2014-10
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2017-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02323672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02323672, "Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02323672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*